Navigation Links
Mayo Clinic Proceedings January tip sheet
Date:1/18/2008

ffect of selenium in lowering the risk of prostate cancer is currently underway.

The bottom line according to Aditya Bardia, M.D., lead author of the study, is that antioxidants do not lower the risk of cancer and beta carotene might actually increase cancer risk among smokers. Selenium might have beneficial properties, but it cannot be recommended for general use until more evidence is available.

In addition to Drs. Montori and Bardia, authors of the article include James Cerhan, M.D., Ph.D.; Amit Sood, M.D.; Paul Limburg, M.D.; and Patricia Erwin, all of Mayo Clinic; and Imad Tleyjeh, M.D., King Fahd Medical City, Riyadh, Saudi Arabia.


Researchers Issue Practical Guidelines for Workplace Drug Screening

Commonly used in health care, workplace and criminal settings, drug testing has become widespread during the past decade. Urine drug screens have been the most common method for analysis because of ease of sampling. But this form of testing does not always yield accurate results, and serious medical or social consequences can occur when results are not confirmed by additional testing. In the January issue of Mayo Clinic Proceedings, researchers provide up-to-date information about proper evaluation of urine drug screens. The authors also examine the potential problems associated with testing for several commonly abused drugs (including alcohol, amphetamines, benzodiazepines, opioids, marijuana, cocaine, phencyclidine (PCP), and tricyclic antidepressants) and they discuss how to evaluate urine drug screens for adulterations, substitutions and potential false-positive results.

Authors of this article are Karen Moeller, PharmD., Pharmacy School, University of Kansas Medical Center, Kansas City; Kelly Lee, PharmD., Department of Clinical Pharmacy, UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, Calif.; and Julie Kissack, PharmD., Department of Pharmacy Practice, Mercer Univer
'/>"/>

Contact: John Murphy
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic
2. New clinical trial results show how personalized medicine will alter treatment of genetic disorders
3. New clinical data shows chromium picolinate improves cognitive function
4. Mayo Clinic study: Ossurs collars superior in immobilization and reduction of pressure
5. Study of African traditional medicine will begin world-first clinical trial
6. Mutant sperm guide clinicians to new diseases
7. Titanium Group Announces Biometric Contract with One of the Most Active Clinics in Hong Kong
8. Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design
9. Cleveland Clinic leading clinical program to improve early-stage lung cancer detection
10. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
11. Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... Between 1970 and 2010 populations of mammals, birds, ... 52 percent, says the 2014 Living Planet Report ... biodiversity loss occurs disproportionately in low-income countriesand correlates ... , In addition to the precipitous decline in ... warning signs about the overall health of the ...
(Date:9/29/2014)... world,s needs to make cheaper and more effective ... efficient catalytic materials and processes must be developed. ... State University, is tackling this problem with the ... Science Foundation. , The nearly $1.5 million project, ... Cascade Reactions," was to Eranda Nikolla, Ph.D., assistant ...
(Date:9/29/2014)... Ill. University of Illinois scientists have found compounds ... found them in a pretty unlikely placethe crushed seeds ... in jet fuel. , "The bioactive compounds in ... Pleasure, are a mixture of phytochemicals that work ... seed meal is a promising nutritional supplement because its ...
Breaking Biology News(10 mins):Half of global wildlife lost, says new WWF report 2Wayne State research aims to develop new, more efficient catalytic materials 2New way to detox? 'Gold of Pleasure' oilseed boosts liver detoxification enzymes 2
... director of Syracuse Biomaterials Institute (SBI) and Milton and ... Syracuse University,s L.C. Smith College of Engineering and Computer ... functionally graded materials (FGMs) to shape memory polymers (SMPs). ... switch between two shapes, from a fixed (temporary) shape ...
... SPRING HARBOR, N.Y. (Jan. 5, 2011) Auxin is a ... aspects of plant development and physiology. A new book, ... overview of auxin and its many roles in plant biology. ... plant research," write the editors, Mark Estelle, Dolf Weijers, Karin Ljung, ...
... Treating fractures in children requires special knowledge of ... and adolescent patients is less often caused by technical ... in this age group. Using the example of treating ... Marburg-Gieen University Medical Center, and Lucas Wessel, University Medical ...
Cached Biology News:Syracuse University team develops functionally graded shape memory polymers 2
(Date:9/30/2014)... , Sept. 30, 2014 Nematicide ... kill nematodes. Nematodes are microscopic parasitic roundworms, found ... and inside other plants and animals. Nematicides have ... or other properties promoting migration through the soil. ... than 1,000 plant-parasitic nematodes. With more than 10,000 ...
(Date:9/30/2014)... Md. , Sept. 30, 2014  RegeneRx ... today announced that it has received a Canadian ... by Actin-Sequestering Peptides.  This patent includes claims using ... numerous other actin-sequestering peptides for these purposes.  The ... About RegeneRx Biopharmaceuticals, Inc. ( www.regenerx.com ) ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 OriginOil Inc. ... high-speed, chemical-free process to clean up large quantities of ... CEO Riggs Eckelberry reported on the launch of the ... a site provided by partner STW Resources . ... 1000 barrels per day (bpd) and achieved a 99.8% ...
(Date:9/30/2014)... Boston, MA (PRWEB) September 30, 2014 ... Core Facility Management Benchmarking study which focuses on ... the common challenges core managers face today. , In ... were revealed. One of note is the year-over-year decrease ... contributions. Core managers appear to be feeling the constraints ...
Breaking Biology Technology:Nematicides Market by Types (Fumigants, Organophosphates, Carbamate and Bio-Nematicides), Applications (Agrochemicals, Industrial, and Others), and Geography (North America, Europe, Asia-Pacific & ROW) - Global Trends & Forecasts to 2019 2RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 2iLab Solutions Announces the Results of the 2014 Core Facility Benchmarking Study 3
... Antipsychotic Agent with Less Potential for ... and Metabolic Risks, SAN DIEGO, July 29 ... the United States Patent and,Trademark Office (USPTO) issued a ... broad coverage for a pharmaceutical,composition of zonisamide in combination ...
... up to 50% sucrose reduction while maintaining the sweet taste ... ... July 29, 2008 Senomyx, Inc.,(Nasdaq: SNMX ), a leading ... ingredients for the food, beverage,and ingredient supply industries, announced today that ...
... July 29 Zenobia Therapeutics, Inc.,(Zenobia) announced ... Development,Initiative award from The Michael J. Fox ... research with potential to,fundamentally alter the course ... Dr. Christopher Ross of Johns Hopkins University,Zenobia ...
Cached Biology Technology:OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003 2OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003 3OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003 4SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER 2SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER 3SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER 4Zenobia Therapeutics, Inc. Receives Michael J. Fox Foundation for Parkinson's Research Award for Work on PD-implicated Protein LRRK2 2
Application: for RNase- decontamination , Registered Trademark of Ambion. ,Special grade: for molecular biology Density: 1.00 g/mL (20 C) Suitab tst: RNase decontamination in accordance...
... Application: A cleaning agent for ... surfaces, countertops, and pipettors. ... eliminating RNase contamination from microcentrifuge ... reactions. ,RNase Zap (R) ...
Mol wt: average mol wt12,360.96 Da by calculation...
... is part of a series of media originally ... Weiss et al. for the large scale propagation ... medium is primarily used for the growth and ... the propagation of viruses in these cell lines. ...
Biology Products: